Works matching IS 15430790 AND DT 2020 AND VI 18 AND IP 3
Results: 7
The Role of PARP Inhibitors in Germline BRCA-Associated Pancreatic Ductal Adenocarcinoma.
- Published in:
- Clinical Advances in Hematology & Oncology, 2020, v. 18, n. 3, p. 168
- By:
- Publication type:
- Article
Reflections on 45 Years As a Clinical Hematologist.
- Published in:
- Clinical Advances in Hematology & Oncology, 2020, v. 18, n. 3, p. 160
- By:
- Publication type:
- Article
Highlights From the 2019 San Antonio Breast Cancer Symposium.
- Published in:
- Clinical Advances in Hematology & Oncology, 2020, v. 18, n. 3, p. 157
- By:
- Publication type:
- Article
Prostate Cancer in African American Men.
- Published in:
- Clinical Advances in Hematology & Oncology, 2020, v. 18, n. 3, p. 154
- By:
- Publication type:
- Article
How Disease Stage Impacts the Rate of Second Primary Malignancies in Patients With Diffuse Large B-Cell Lymphoma.
- Published in:
- Clinical Advances in Hematology & Oncology, 2020, v. 18, n. 3, p. 147
- By:
- Publication type:
- Article
Inclusion of Biopsies in Clinical Trials of Oncology Drugs.
- Published in:
- Clinical Advances in Hematology & Oncology, 2020, v. 18, n. 3, p. 144
- By:
- Publication type:
- Article
What Can We Learn From Cancer Disparities?
- Published in:
- Clinical Advances in Hematology & Oncology, 2020, v. 18, n. 3, p. 134
- By:
- Publication type:
- Article